Latest / Community Health Media
Dr. Jason Mouabbi, Dr. Alison Conlin & Dr. Reva Basho - Frontline TNBC and ADC Advances
TNBC has long been one of the most difficult breast cancer subtypes to treat. But with ADCs reshaping the treatment landscape, are we finally entering a new era for metastatic TNBC?
In this in-depth discussion, Dr. Jason Mouabbi, Dr. Alison Conlin, and Dr. Reva Basho explore the rapidly evolving first-line treatment landscape for metastatic triple-negative breast cancer, with a particular focus on patients who are PD-L1 negative or otherwise ineligible for immunotherapy.
The panel reviews the landmark TROPION-Breast02 and ASCENT-03 trials, examining how Dato-DXd and sacituzumab govitecan are…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.